Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Living Cell Technologies ( (AU:1AI) ) is now available.
Algorae Pharmaceuticals Limited has announced the issuance of 60,000,000 unquoted performance rights as part of previously announced transactions. This move is part of their strategic financial maneuvers and does not involve securities intended to be quoted on the ASX, indicating a focus on internal stakeholder incentives and long-term company growth.
More about Living Cell Technologies
Average Trading Volume: 10,231,180
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$14.34M
Find detailed analytics on 1AI stock on TipRanks’ Stock Analysis page.